Voyager Therapeutics
VYGR · NASDAQ
$2.19+$0.14 (+6.83%)TodayMarket closed ·
Prev close $2.05
Who owns VYGR
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 50.2% of VYGR’s shares.
- Neurocrine Biosciences Inc14.2%
- Millennium Management LLC7.4%
- BlackRock Institutional Trust Company, N.A.7.2%
- Armistice Capital LLC5.7%
- Next 6 largest institutions15.7%
- All other shareholders49.8%
| Holder | Shares | % of shares |
|---|---|---|
| Neurocrine Biosciences Inc | 8.58M | 14.19% |
| Millennium Management LLC | 4.44M | 7.35% |
| BlackRock Institutional Trust Company, N.A. | 4.37M | 7.24% |
| Armistice Capital LLC | 3.44M | 5.69% |
| Vestal Point Capital, LP | 2.63M | 4.34% |
| Vanguard Capital Management, LLC | 2.35M | 3.88% |
| Geode Capital Management, L.L.C. | 1.33M | 2.20% |
| Opaleye Management Inc. | 1.19M | 1.96% |
| State Street Investment Management (US) | 1.08M | 1.78% |
| Two Sigma Investments, LP | 948.52K | 1.57% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.67M | 2.77% |
| iShares Russell 2000 ETF | 1.37M | 2.27% |
| Vanguard Extended Market Index Fund | 613.13K | 1.01% |
| Fidelity Small Cap Index Fund | 571.14K | 0.95% |
| iShares Russell 2000 Value ETF | 485.89K | 0.80% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of VYGR in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| MACKEY CATHERINE J | Award | 30.00K | — |
| Hyman Steven | Award | 30.00K | — |
| Vitale Nancy | Award | 30.00K | — |
| Onyia Jude | Award | 30.00K | — |
| Colon Grace | Award | 30.00K | — |
| Higgins Michael J | Award | 30.00K | — |
| PIERCE GLENN | Award | 30.00K | — |
| GERAGHTY JAMES A | Award | 30.00K | — |
| SCANGOS GEORGE A | Award | 30.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 3.97M
- Days to cover
- 6.43
- % of shares outstanding
- 6.58%
- Average daily volume
- 618.06K
- Change since last report
- +8.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.